Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
10 NOK | -2.91% | -1.96% | -4.76% |
Mar. 01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
Sales 2024 * | 57M 5.43M | Sales 2025 * | 79M 7.53M | Capitalization | 261M 24.9M |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.86M | Net income 2025 * | -50M -4.76M | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | 157M 14.96M | Net cash position 2025 * | 106M 10.1M | EV / Sales 2025 * | 1.97 x |
P/E ratio 2024 * |
-8.56
x | P/E ratio 2025 * |
-5.17
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.42% |
Latest transcript on Arctic Bioscience
1 day | -2.91% | ||
1 week | -1.96% | ||
Current month | -2.91% | ||
1 month | -4.76% | ||
3 months | +3.09% | ||
6 months | +14.94% | ||
Current year | -4.76% |
Managers | Title | Age | Since |
---|---|---|---|
Hogne Hallaråker
FOU | Founder | 58 | 10-12-31 |
Chief Executive Officer | 52 | 22-02-28 | |
Jone R. Slinning
DFI | Director of Finance/CFO | 45 | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 44 | 20-12-31 | |
Director/Board Member | 55 | 19-12-31 | |
Harald Nordal
FOU | Founder | 66 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 10 | -2.91% | 9 000 |
24-05-31 | 10.3 | -0.96% | 4,000 |
24-05-30 | 10.4 | +4.00% | 10,581 |
24-05-29 | 10 | +3.63% | 1,001 |
24-05-28 | 9.65 | -5.39% | 343 |
Real-time Oslo Bors, June 03, 2024 at 05:14 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.76% | 24.85M | |
+40.73% | 739B | |
+31.39% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.19% | 240B | |
+9.39% | 210B | |
-5.32% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ABS Stock